Clinical Trial

A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This single-center, retrospective, 7-year observational study aims to investigate prognostic factors in esophageal cancer patients. Adults (≥18 years) with histologically confirmed esophageal cancer who received antitumor therapy between January 2017 and December 2024 were consecutively enrolled. Patient-level data (clinical characteristics, routine laboratory tests, tumor information, and treatment details) were retrospectively collected from electronic medical records to analyze key factors influencing treatment efficacy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-29.
Trial Details
NCT Number NCT06960889
Lead Sponsor Nanfang Hospital, Southern Medical University
Conditions Esophageal Cancer (EsC)
Enrollment 500 participants
Start Date 2025-04-15
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-14